The estimated Net Worth of Ronald D Green is at least $282 Thousand dollars as of 29 August 2024. Ronald Green owns over 4,446 units of Neogen stock worth over $193,950 and over the last 9 years he sold NEOG stock worth over $0. In addition, he makes $88,376 as Independent Director at Neogen.
Sign up
Ronald Green NEOG stock SEC Form 4 insiders trading
Ronald has made over 3 trades of the Neogen stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 4,446 units of NEOG stock worth $68,780 on 29 August 2024.
The largest trade he's ever made was exercising 4,446 units of Neogen stock on 29 August 2024 worth over $68,780. On average, Ronald trades about 857 units every 215 days since 2015. As of 29 August 2024 he still owns at least 12,718 units of Neogen stock.
You can see the complete history of Ronald Green stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ronald Green biography
Dr. Ronald D. Green Ph.D. serves as Independent Director of the Company. He was appointed Chancellor of the University of Nebraska-Lincoln in April 2016. Prior to that appointment, he was the Harlan Vice Chancellor of the Institute of Agriculture and Natural Resources and Vice President for Agriculture and Natural Resources of the University of Nebraska system since 2010. Dr. Green served as senior global director of technical services at Pfizer Animal Health’s animal genomics business from 2008 to 2010. He was on faculty at Texas Tech University and Colorado State, and was the national program leader for animal production research for the USDA’s Agricultural Research Service and executive secretary of the White House’s interagency working group on animal genomics within the National Science and Technology Council. In that role, he was a leader in the international bovine, porcine and ovine genome sequencing projects. Dr. Green is a past president of the American Society of Animal Science (“ASAS”) and the National Block and Bridle Club, and has served in a number of leadership positions for the U.S. Beef Improvement Federation, National Cattlemen’s Beef Association, National Pork Board, Federated Animal Science Societies, and the National Research Council. Dr. Green was named a fellow of ASAS in 2014. Dr. Green’s experience in genomics and animal production research brings great value and insight to the Board.
What is the salary of Ronald Green?
As the Independent Director of Neogen, the total compensation of Ronald Green at Neogen is $88,376. There are 8 executives at Neogen getting paid more, with John Adent having the highest compensation of $2,123,450.
How old is Ronald Green?
Ronald Green is 59, he's been the Independent Director of Neogen since 2014. There are 4 older and 9 younger executives at Neogen. The oldest executive at Neogen Corp. is G. Bruce Papesh, 73, who is the Independent Director.
What's Ronald Green's mailing address?
Ronald's mailing address filed with the SEC is Neogen, 620, Lesher Place, Oak Park, Lansing, Ingham County, Michigan, 48912, United States.
Insiders trading at Neogen
Over the last 24 years, insiders at Neogen have traded over $135,917,555 worth of Neogen stock and bought 195,554 units worth $4,379,833 . The most active insiders traders include James L Herbert, Jeffrey D Capello, and Lon M Bohannon. On average, Neogen executives and independent directors trade stock every 11 days with the average trade being worth of $140,346. The most recent stock trade was executed by Ronald D Green on 29 August 2024, trading 4,446 units of NEOG stock currently worth $68,780.
What does Neogen do?
neogen corporation develops and markets products dedicated to food and animal safety. the company’s food safety division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. neogen’s animal safety division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides.
What does Neogen's logo look like?
Complete history of Ronald Green stock trades at Neogen
Neogen executives and stock owners
Neogen executives and other stock owners filed with the SEC include:
-
John Adent,
President, Chief Executive Officer, Director -
Steven Quinlan,
Chief Financial Officer, Vice President, Secretary -
John Edward Adent,
Pres, CEO & Director -
Jason Lilly,
Vice President - International Business -
Jerome Hagedorn,
Vice President - Food Safety operations -
Douglas E. Jones,
VP & Chief Commercial Officer -
Steven J. Quinlan,
VP & CFO -
James Borel,
Lead Independent Chairman of the Board -
James Tobin,
Independent Director -
Ronald Green,
Independent Director -
William Boehm,
Independent Director -
Darci Vetter,
Independent Director -
G. Bruce Papesh,
Independent Director -
Doug Jones,
Chief Commercial Officer -
Amy M. Rocklin Ph.D.,
VP, Gen. Counsel & Corp. Sec. -
Julie A. Mann,
VP & Chief HR Officer -
Rod Poland,
Director of Corp. Communications -
Amy Rocklin Ph.D.,
VP & Gen. Counsel -
Sarah Demey,
Admin. Mang. -
Bruce Papesh,
Director -
A Charles Fischer,
Director -
Richard E Jr Calk,
President & COO -
Richard T Crowder,
Director -
Jack C Parnell,
Director -
Clayton K Yeutter,
Director -
Thomas H Reed,
Director -
Terri A Morrical,
-
David H. Naemura,
Chief Financial Officer -
Edward Bradley,
V.P. Sales and Marketing -
Aashima Gupta,
Director -
Jeffrey D Capello,
Director -
Rex L Hamilton,
Vice President -
Herbert D Doan,
Director -
Gordon E Guyer,
Director -
James L Herbert,
Director -
Joseph M Madden,
V.P. Scientific Affairs -
Richard R Current,
Vice President & CFO -
Anthony E Maltese,
VP Business Development -
Kenneth V Kodilla,
Vice President -
Lon M Bohannon,
COO -
Mark A Mozola,
Vice President of R&D -
Leonard E Heller,
Director -
Robert M Book,
Director -
Stephen K. Snyder,
Former Pres. and COO -
Paul S Satoh,
V.P Research and Development -
Rafael A Rodriguez,
Director -
Catherine E Woteki,
Director -
Amy M Rocklin,
Chief Legal Officer -
John Patrick Moylan,
Chief Accounting Officer